Cyanokit (Hydroxocobalamin Vials) 5g/250ml

Cyanokit (hydroxocobalamin 5g/250ml) is an injectable cyanide antidote supplied in a single 250 mL vial. It is used for emergency treatment of known or suspected cyanide poisoning in adults and pediatric patients. This product is stored at controlled room temperature for stability.

Strength

5g/250ml

Pack Size

Storage

15-25°

Manufacturer / TM Owner

Meridian Medical Technologies,Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Hydroxocobalamin is used to treat cyanide poisoning, a serious condition that can occur from smoke inhalation, chemical exposure, or certain industrial accidents. It works by binding cyanide ions to form cyanocobalamin, which is then excreted in urine. This medication is indicated for patients exhibiting symptoms such as confusion, shortness of breath, or loss of consciousness. It is administered intravenously by healthcare professionals.

Side Effects

After administration, hydroxocobalamin may temporarily turn the skin and urine a reddish color. Some patients report mild headache, nausea, or dizziness during or after treatment. These effects are generally short-lived and resolve without intervention. The solution is ready for direct intravenous use and does not require dilution.

Precautions & Warnings

Store Cyanokit between 15–25°C and protect from light. Inspect the vial for particles or discoloration before use; discard if present. Use within the labeled expiration date and avoid freezing. Keep out of reach of children and pets. Ensure proper handling and disposal according to medical waste guidelines.

Avoid Interactions

No formal drug interaction studies have been conducted. Cyanokit has been used concurrently with other emergency medications without reported issues. However, caution is advised when co-administering with medications that may affect blood pressure or heart rate. Always inform healthcare providers of all medications currently being taken.

Frequently Asked Questions

Hydroxocobalamin is primarily used to treat cyanide poisoning in emergency settings.

Cyanokit is given as an intravenous injection by a healthcare professional.

Common effects include temporary reddish skin or urine discoloration, mild headache, or nausea.

Yes, Cyanokit is approved for use in both adults and pediatric patients with cyanide poisoning.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.